Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya.

ABSTRACT: New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women for receiving a newly licensed vaccine during pregnancy. Pregnant and lactating women from two counties in Kenya, Nakuru and Mombasa, were recruited to complete a cross-sectional survey in July-September 2022. The survey explored topics of trust in various types of sources for information about new maternal vaccines, the importance of a healthcare

SUBMITTER: Schue JL 

PROVIDER: S-EPMC12611154 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature